Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.51 0.31 (0.48%) as of 4:30 Wed 5/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.89(B)
Last Volume: 7,231,910 Avg Vol: 8,754,576
52 Week Range: $65.27 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2493
  Page 2 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Parsey Merdad Chief Medical Officer   •       •      –    2024-01-31 4 D $78.26 $1,855,466 D/D (23,709) 102,616     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-01-31 4 A $0.00 $0 D/D 76,853 126,325     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-01-25 4 D $80.23 $15,565 D/D (194) 7,082     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-01-25 4 OE $0.00 $0 D/D 514 7,276     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-01-16 4 AS $85.78 $428,900 D/D (5,000) 101,534 -24%     
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-01-09 4 AS $85.23 $702,466 D/D (8,242) 82,729 -24%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-12-10 4 D $79.02 $94,350 D/D (1,194) 106,534     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-12-10 4 OE $0.00 $0 D/D 2,617 107,728     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-12-10 4 D $79.02 $100,276 D/D (1,269) 71,640     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-12-10 4 OE $0.00 $0 D/D 2,779 72,909     -
   Patterson Sandra SVP, Controllership   •       •      –    2023-12-10 4 D $79.02 $17,542 D/D (222) 30,420     -
   Patterson Sandra SVP, Controllership   •       •      –    2023-12-10 4 OE $0.00 $0 D/D 518 30,642     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-12-10 4 D $79.02 $98,538 D/D (1,247) 90,971     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-12-10 4 OE $0.00 $0 D/D 2,730 92,218     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-12-10 4 D $79.02 $264,006 D/D (3,341) 387,691     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-12-10 4 OE $0.00 $0 D/D 7,347 391,032     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-11-10 4 D $75.92 $61,040 D/D (804) 105,111     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-11-10 4 OE $0.00 $0 D/D 1,912 105,915     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2023-10-25 4 D $78.39 $19,049 D/D (243) 6,762     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2023-10-25 4 OE $0.00 $0 D/D 514 7,005     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-10-17 4 AS $80.00 $400,017 D/D (5,000) 104,003 -9%     
   Parsey Merdad Chief Medical Officer   •       •      –    2023-09-12 4 AS $76.99 $115,562 D/D (1,501) 70,130 2%     
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-09-10 4 D $76.00 $95,456 D/D (1,256) 89,488     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-09-10 4 OE $0.00 $0 D/D 2,730 90,744     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-09-10 4 D $76.00 $255,816 D/D (3,366) 383,685     -
  2493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us